<?xml version="1.0" encoding="UTF-8"?>
<p>Vaccination programs provide a degree of social mobility, as poverty and the associated ill-health and mortality from infectious diseases are no longer the determinants of oneâ€™s life chances. Vaccine recipients have the potential for improved life-expectancy largely demonstrated by, but not confined to, infants and children (
 <xref rid="B4" ref-type="bibr">Andre et al., 2008</xref>). It has become increasingly recognized that an aging population goes through the process of immunosenescence (
 <xref rid="B33" ref-type="bibr">Fulop et al., 2017</xref>), and increased incidence and severity of infectious diseases. In many countries, therefore, older people are offered vaccines to prevent infections with high mortality and morbidity, including the influenza, pneumococcal, herpes zoster, and pertussis vaccines (
 <xref rid="B16" ref-type="bibr">Bonanni et al., 2015</xref>). These prevent the development of pneumonia, admission to hospital and the subsequent associated risks of death from cardiac failure, as observed in Sweden (
 <xref rid="B23" ref-type="bibr">Christenson et al., 2004</xref>).
</p>
